CVE:VIR Viridium Pacific Group (VIR) Stock Price, News & Analysis C$0.38 +0.02 (+5.56%) As of 06/7/2019 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Viridium Pacific Group Stock (CVE:VIR) Get Viridium Pacific Group alerts:Sign Up Key Stats Today's RangeC$0.37▼C$0.4150-Day RangeC$0.38▼C$0.3852-Week RangeC$0.36▼C$1.15Volume26,500 shsAverage Volume92,632 shsMarket CapitalizationC$37.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada. Read More Receive VIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VIR Stock News HeadlinesHannover Re to exit Viridium consortium, while Santander Insurance buys inAugust 1, 2025 | reuters.comCinven Sells Viridium to Allianz-Led Consortium for $3.8 BillionMarch 19, 2025 | msn.comThe SpaceX filing is public. The window is closing.SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price. | Behind the Markets (Ad)Global Insurer Allianz in Talks for $3 Billion-Plus Viridium DealMarch 7, 2025 | msn.comOrchids Are Highly Prized in the West. In the South Pacific, They’re Everywhere.November 14, 2024 | nytimes.comPacific American Holdings Acquires High-Grade Silver ProjectOctober 28, 2024 | msn.comPacific American Holdings Acquires Promising Silver ProjectOctober 25, 2024 | markets.businessinsider.comPacific Urban Investors acquires Cupertino apartmentsOctober 22, 2024 | bizjournals.comSee More Headlines VIR Stock Analysis - Frequently Asked Questions How have VIR shares performed this year? Viridium Pacific Group's stock was trading at C$0.38 at the beginning of the year. Since then, VIR shares have increased by 0.0% and is now trading at C$0.38. How do I buy shares of Viridium Pacific Group? Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Viridium Pacific Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolCVE:VIR CIKN/A Webwww.viridiumpacific.com Phone604-837-8688FaxN/AEmployees580Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.28 Quick Ratio9.91 Sales & Book Value Annual SalesC$1.09 million Price / Sales34.46 Cash FlowC$0.13 per share Price / Cash Flow2.92 Book ValueC$0.29 per share Price / Book1.30Miscellaneous Outstanding Shares98,733,000Free FloatN/AMarket CapC$37.52 million OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (CVE:VIR) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredTrump Admin to Pump $1 Billion into this “Off-the-Radar” AI StockThe U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...InvestorPlace | SponsoredGold surged 600 dollars last time this indicator peakedThe Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridium Pacific Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridium Pacific Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.